Saunders-Pullman, R., Barrett, M., Stanley, K., San Luciano, M., Shanker, V., Severt, L., . . . Bressman, S. (2010). LRRK2 G2019S Mutations are associated with an increased cancer risk in Parkinson Disease.
Styl ChicagoSaunders-Pullman, R., et al. LRRK2 G2019S Mutations Are Associated With an Increased Cancer Risk in Parkinson Disease. 2010.
Citace podle MLASaunders-Pullman, R., et al. LRRK2 G2019S Mutations Are Associated With an Increased Cancer Risk in Parkinson Disease. 2010.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..